Kurt Kuehn retired in 2015 as UPS’s CFO following a unique career that covered many roles during his 38 year tenure. Prior to his 8 year term as CFO, he was the SVP of Sales and Marketing at UPS from 2004 through 2007. Kurt was also UPS’s first VP of Investor Relations, taking the company public in 1999 – the largest IPO of the 20th century. Since joining the company in 1977 his career also included roles in Engineering, Operations, Planning, Strategy and Business Analytics.
Mr. Kuehn is currently on the boards of Henry Schein, serving as audit committee chair, and of LocatorX, a logistics technology company. As a long time supporter of sustainability programs, he is active as a board member of the Sustainability Accounting Standards Board (SASB). Kurt attended Yale University and received an MBA from the University of Miami.
Karen Teitelbaum is President/CEO of Sinai Health System, Chicago’s largest private healthcare system serving vulnerable communities with over $1 billion of revenues, four hospitals, 3200 employees, research and community institutes. A nationally recognized leader in healthcare, Karen has led a successful turnaround of financial, philanthropic, and operational performance, and focuses on business development, strategy, and advocacy.
Richard Still has a strong background in finance, operations and corporate startups. He has most recently served as CFO of a $100M privately held company. His previous positions included COO of a multi-location environmental company, financial analyst for an investment banking firm and plant manager for a manufacturing company. Richard was also the founder and CEO of three different specialty manufacturing companies.
David Greenspan, Ph.D.
David Greenspan has over 40 years of experience in the medical device industry in numerous capacities. He has served as VP Product Development for Tutogen Medical and RTI Biologics, Chief Technical Officer and co-founder of NovaMin Technologies, VP Research and Development and co-founder of US Biomaterials.
Larry Bottomley, Ph.D.
Research interests are in electroanalytical chemistry, scanning probe microscopy, and surface-enhanced Raman scattering
Richard Crooks, Ph.D.
Research areas include bioanalytical chemistry, electrochemistry, nanotechnology and surface chemistry
Kevin Plaxco, Ph.D.
Specialized in biosensors, electrochemistry, and biomaterials and has co-authored more than 180 papers, a popular science book and more than a dozen patents
Brian is a strategic licensing executive with broad experience in patent licensing. He served as President and COO of A2D, monetizing a portfolio of patents, and collected over $1.4 billion in licensing revenue. He has extensive experience negotiating with educational institutions.
MG Elder Granger, MD
Major General Elder Granger, MD retired after 37 years as Dep. Dir. & Prog Exec Officer of TRICARE, serving as principal advisor to the Asst. Secretary of Defense. He oversaw the DoD’s managed care program, a $19 billion defense health program serving 9.4 million. He has led at every level of the Army Medical Department. Dr. Granger earned his MD from the University of Arkansas School of Medicine.
MG Richard Haddad
Major General Richard “Beef” Haddad, founding partner at Two Blue Aces, retired after 35 yrs as Vice Commander, Air Force Reserve Command, where he directed daily operations and served as Deputy Chief in the Pentagon. He earned 3 Distinguished Flying Crosses with “V for Valor” device, and 5 Air Medals. He has deployed to combat zones 8 times during his career.
MG Lawrence Martin
Major General Lawrence “Larry” Martin is a Senior Consultant with Two Blue Aces. A command pilot who served in the Air Force for over 32 years, he served as Assistant Deputy Under Secretary of the Air Force, International Affairs, overseeing the Air Force’s international affairs program, including the $187 billion dollar FMS portfolio.